Drug Shortage Report for APO-LAMIVUDINE

Last updated on 2021-02-27 History
Report ID 134757
Drug Identification Number 02369060
Brand name APO-LAMIVUDINE
Common or Proper name LAMIVUDINE
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) LAMIVUDINE
Strength(s) 300MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 30 BTL
ATC code J05AF
ATC description DIRECT ACTING ANTIVIRALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-02-26
Estimated end date 2021-06-25
Actual end date
Shortage status Actual shortage
Updated date 2021-02-27
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2021-02-27 English Compare
v2 2021-02-26 French Compare
v1 2021-02-26 English Compare